Srivilaithon Winchana, Muengtaweepongsa Sombat
1 Department of Emergency Medicine, Thammasat University Hospital , Pathumthani, Thailand .
2 Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Thammasat University Hospital , Pathumthani, Thailand .
Ther Hypothermia Temp Manag. 2017 Mar;7(1):24-29. doi: 10.1089/ther.2016.0014. Epub 2016 Nov 11.
Targeted temperature management (TTM) is indicated for comatose survivors of cardiac arrest to improve outcomes. However, the benefit of TTM was verified by rigid controlled clinical trials. This study aimed at evaluating its effects in real-world practices. A prospective observational study was done at the emergency department of tertiary care, Thammasat Hospital, from March 2012 until October 2015. We included all who did not obey verbal commands after being resuscitated from cardiac arrest regardless of initial cardiac rhythm. We excluded patients with traumatic arrest, uncontrolled bleeding, younger than 15 years old, and of poor neurological status (Glasgow coma scale below 14) before cardiac arrest. Primary and secondary outcomes were survival to hospital discharge and favorable neurological outcome (Cerebral Performance Categories 1 or 2 within 30 days). We used the logistic regression model to estimate the propensity score (PS) that will be used as a weight in the analysis. To analyze outcomes, the PS was introduced as a factor in the final logistic regression model in conjunction with other factors. A total of 192 cases, 61 and 131 patients, were enrolled in TTM and non-TTM groups, respectively. Characteristics believed to be related to initiation of TTM: gender, age, cardiac etiology, out-of-hospital cardiac arrest, witness arrest, collapse time, initial rhythm, received defibrillation, and advanced airway insertion, were included in multivariable analysis and estimated PS. After adjusted regression analysis with PS, the TTM group had a better result in survival to hospital discharge (34.43% vs. 12.21%; adjusted incidence risk ratio (IRR), 2.95; 95% confidence interval (CI), 1.49-5.84; p = 0.002). For neurological outcome, the TTM group had a higher number of favorable neurological outcomes (24.59% vs. 6.87%; IRR, 3.96; 95% CI, 1.67-9.36; p = 0.002). In real-world practices without a strictly controlled environment, TTM can improve survival and favorable neurological outcome in postcardiac arrest patients regardless of initial rhythm.
目标温度管理(TTM)适用于心脏骤停后的昏迷幸存者以改善预后。然而,TTM的益处是通过严格的对照临床试验验证的。本研究旨在评估其在实际临床实践中的效果。2012年3月至2015年10月,在泰国国立法政大学医院急诊科进行了一项前瞻性观察性研究。我们纳入了所有心脏骤停复苏后对言语指令无反应的患者,无论其初始心律如何。我们排除了创伤性心脏骤停、出血无法控制、年龄小于15岁以及心脏骤停前神经功能状态不佳(格拉斯哥昏迷量表低于14分)的患者。主要和次要结局分别是存活至出院以及良好的神经功能结局(30天内脑功能分类为1或2级)。我们使用逻辑回归模型来估计倾向得分(PS),该得分将在分析中用作权重。为了分析结局,PS作为一个因素与其他因素一起被纳入最终的逻辑回归模型。TTM组和非TTM组分别纳入了192例患者,其中61例和131例。被认为与启动TTM相关的特征:性别、年龄、心脏病因、院外心脏骤停、目睹心脏骤停、倒地时间、初始心律、接受除颤以及置入高级气道,被纳入多变量分析并估计PS。经过PS调整后的回归分析,TTM组在存活至出院方面有更好的结果(34.43%对12.21%;调整后的发病率风险比(IRR),2.95;95%置信区间(CI),1.49 - 5.84;p = 0.002)。对于神经功能结局,TTM组有更多良好的神经功能结局(24.59%对6.87%;IRR,3.96;95%CI,1.67 - 9.36;p = 0.002)。在没有严格控制环境的实际临床实践中,无论初始心律如何,TTM都可以改善心脏骤停后患者的生存率和神经功能良好结局。